Literature DB >> 10051068

Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson's syndrome.

J C DeToledo1, A Minagar, M R Lowe, R E Ramsay.   

Abstract

Skin eruptions have been reported with the use of all antiepileptic drugs and there is a significant risk of cross-reactivity between these agents in causing serious eruptions such as Stevens-Johnson's syndrome. Gabepentin is usually considered a safe agent for patients with a previous history of drug allergies and there have been no cases of skin eruption reported to the gabapentin post marketing surveillance. We report a patient who had severe Stevens-Johnson's syndrome induced by phenytoin and later by carbamazepine. Subsequent use of gabapentin also resulted in a skin eruption which was limited to the lower extremities but without systemic or mucosal involvement. This case suggests that patients with a strong history of drug-induced idiosyncratic reactions may experience such reactions to gabapentin as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051068     DOI: 10.1097/00007691-199902000-00022

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

Review 1.  Antiepileptic hypersensitivity syndrome: clinicians beware and be aware.

Authors:  Olga Bessmertny; Trinh Pham
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 2.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

3.  Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.

Authors:  Ji Young Kim; Joongyub Lee; Young-Jin Ko; Ju-Young Shin; Sun-Young Jung; Nam-Kyong Choi; Byung-Joo Park
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.